H. Tawada

发表

TMP-153, a novel ACAT inhibitor, inhibits cholesterol absorption and lowers plasma cholesterol in rats and hamsters.

E. Ishikawa, H. Ikeda, Y. Sugiyama, 1995, Atherosclerosis.

Ligand-free Heck–Mizoroki reaction for 1,3,5-Trisubstituted Pyrazoles

H. Tawada, Misayo Sera, Hideya Mizufune, 2015 .

Studies on antidiabetic agents. I. Synthesis of 5-[4-(2-methyl-2-phenylpropoxy)-benzyl]thiazolidine-2,4-dione (AL-321) and related compounds.

T. Sohda, T. Fujita, Y. Sugiyama, 1982, Chemical & pharmaceutical bulletin.

TAK-599, a novel N-phosphono type prodrug of anti-MRSA cephalosporin T-91825: synthesis, physicochemical and pharmacological properties.

Y. Ikeda, T. Ishikawa, Y. Tagawa, 2003, Bioorganic & medicinal chemistry.

Synthesis and biological activity of novel 5-(omega-aryloxyalkyl)oxazole derivatives as brain-derived neurotrophic factor inducers.

T. Maekawa, Y. Momose, Nozomu Sakai, 2003, Chemical & pharmaceutical bulletin.

STUDIES ON ANTIDIABETIC AGENTS. III. 5-ARYLTHIAZOLIDINE-2,4-DIONES AS POTENT ALDOSE REDUCTASE INHIBITORS

T. Sohda, E. Imamiya, K. Meguro, 1983 .

Heterocycles. VI. Syntheses of 4H-s-Triazolo [4,3-a] [1,4] benzodiazepines, Novel Tricyclic Psychosedatives

H. Miyano, K. Meguro, Yoshiaki Sato, 1973 .

Heterocycles. VII. Novel and Facile Syntheses of s-Triazolo-[4, 3-a] [1, 4] benzodiazepine Derivatives

K. Meguro, H. Tawada, Y. Kuwada, 1973 .

Studies on antidiabetic agents. VII. Synthesis and hypoglycemic activity of 4-oxazoleacetic acid derivatives.

T. Fujita, K. Meguro, Y. Sugiyama, 1986, Chemical & pharmaceutical bulletin.

A convenient ring formation of 3-aryl-2,2-dialkyl-2,3-dihydrobenzofurans from phenols and 2-aryl-2,2-dialkylacetaldehydes

M. Yamashita, Yuji Ono, H. Tawada, 2004 .

Synthesis and biological activities of new 1,4-benzothiazine derivatives.

M. Kajino, K. Meguro, H. Tawada, 1991, Chemical & pharmaceutical bulletin.

Studies on antidiabetic agents. IX. A new aldose reductase inhibitor, AD-5467, and related 1,4-benzoxazine and 1,4-benzothiazine derivatives: synthesis and biological activity.

Y. Yamamoto, K. Meguro, H. Ikeda, 1990, Chemical & pharmaceutical bulletin.

Studies on antidiabetic agents. III. 5-Arylthiazolidine-2,4-diones as potent aldose reductase inhibitors.

T. Sohda, Y. Yamamoto, E. Imamiya, 1982, Chemical & pharmaceutical bulletin.

Development of Large-Scale Synthesis using a Palladium-Catalyzed Cross-Coupling Reaction for an Isoquinolone Derivative as a Potent DPP-4 Inhibitor

M. Yamashita, H. Tawada, Yuujirou Ono, 2014 .

Synthesis of 3-ureido derivatives of coumarin and 2-quinolone as potent acyl-CoA: cholesterol acyltransferase inhibitors.

H. Natsugari, E. Ishikawa, K. Meguro, 1995, Chemical & pharmaceutical bulletin.

Heterocycles. IV. Reactions of 2-Amino-3H-1, 4-benzodiazepines with Primary Amines and Hydroxylamines

K. Meguro, H. Tawada, Y. Kuwada, 1973 .

HETEROCYCLES PART 4, REACTIONS OF 2-AMINO-3H-1,4-BENZODIAZEPINES WITH PRIMARY AMINES AND HYDROXYLAMINES

H. Natsugari, K. Meguro, H. Tawada, 1974 .

HETEROCYCLES PART 7, NOVEL AND FACILE SYNTHESES OF S‐TRIAZOLO‐(4,3‐A)(1,4)‐BENZODIAZEPINE DERIVATIVES

K. Meguro, H. Tawada, Y. Kuwada, 1973 .